Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial.
Rheumatol Ther. 2024 Jun;11(3):617-632. doi: 10.1007/s40744-024-00654-5. Epub 2024 Mar 18.
Rheumatol Ther. 2024.
PMID: 38498141
Free PMC article.
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial.
Östör A, Van den Bosch F, Papp K, Asnal C, Blanco R, Aelion J, Carter K, Stakias V, Lippe R, Drogaris L, Soliman AM, Chen MM, Padilla B, Kivitz A.
Östör A, et al. Among authors: drogaris l.
Rheumatol Ther. 2024 Jun;11(3):633-648. doi: 10.1007/s40744-024-00657-2. Epub 2024 Mar 18.
Rheumatol Ther. 2024.
PMID: 38498139
Free PMC article.
Item in Clipboard
Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse).
Stein Gold LF, Bagel J, Tyring SK, Hong HC, Pavlovsky L, Vender R, Pinter A, Reich A, Drogaris L, Wu T, Patel M, Soliman AM, Photowala H, Stakias V, Richter S, Papp KA.
Stein Gold LF, et al. Among authors: drogaris l.
Br J Dermatol. 2023 Oct 25;189(5):540-552. doi: 10.1093/bjd/ljad252.
Br J Dermatol. 2023.
PMID: 37488811
Clinical Trial.
Item in Clipboard
Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial.
Kimball AB, Prens EP, Passeron T, Maverakis E, Turchin I, Beeck S, Drogaris L, Geng Z, Zhan T, Messina I, Bechara FG.
Kimball AB, et al. Among authors: drogaris l.
Dermatol Ther (Heidelb). 2023 May;13(5):1099-1111. doi: 10.1007/s13555-023-00913-3. Epub 2023 Mar 9.
Dermatol Ther (Heidelb). 2023.
PMID: 36892753
Free PMC article.
Item in Clipboard
A qualitative evaluation of patient and healthcare provider knowledge, attitudes, and behavior for safety and use of pexidartinib.
Salas M, Julian M, Drogaris L, Islam Z, Henderson M, Stemhagen A, O'Donnell N, Tu N.
Salas M, et al. Among authors: drogaris l.
J Comp Eff Res. 2021 Feb;10(3):187-192. doi: 10.2217/cer-2020-0147. Epub 2021 Jan 21.
J Comp Eff Res. 2021.
PMID: 33474977
Free article.
Item in Clipboard
Cite
Cite